Healthcare Services

Global Gastric Cancer Diagnostic Procedure Market Revenue Expected To Reach $2.22 Billion By 2030

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Value Trend Is Expected For The Gastric Cancer Diagnostic Procedure Market From 2026 To 2030?

The gastric cancer diagnostic procedure market has shown substantial expansion in recent years. It is anticipated to increase from $1.54 billion in 2025 to $1.65 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.4%. This past growth can be attributed to the implementation of endoscopy in gastric diagnosis, the widespread use of biopsy procedures, the availability of imaging tests, the presence of hospital-based diagnostic infrastructure, and the establishment of pathology laboratories.

The gastric cancer diagnostic procedure market is projected to experience robust expansion over the coming years. This market is forecast to reach $2.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during the projected period include the advancements in liquid biopsy techniques, the broadening scope of molecular diagnostics, the increasing need for early disease detection, automation within diagnostic workflows, and the integration of AI-enabled imaging analysis. Key trends anticipated during the forecast timeframe encompass the expanding utilization of endoscopic diagnostic methods, the increasing embrace of molecular and genetic testing, a heightened call for identifying cancer in its early stages, the proliferation of non-invasive diagnostic procedures, and the incorporation of sophisticated imaging technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp

What Are The Main Drivers Accelerating The Growth Of The Gastric Cancer Diagnostic Procedure Market?

The growing increase in smoking is anticipated to boost the expansion of the gastric cancer diagnostic procedure market moving forward. Smoking is defined as the process of inhaling and exhaling smoke generated by burning tobacco or other substances. Gastric cancer diagnostic procedures are essential for individuals with a history of smoking or those susceptible to smoking-related cancers, as they facilitate early detection and identification of precancerous lesions, assist in crafting personalized and tailored treatment plans, enhance communication and coordination, and offer a comprehensive evaluation of the gastric mucosa and adjacent tissues. For instance, in July 2023, a report from the World Health Organization, a Switzerland-based intergovernmental organization, revealed that tobacco claims the lives of over 8 million people each year, encompassing 1.3 million non-smokers who breathe in second-hand smoke. Thus, the escalating prevalence of smoking is propelling the growth of the gastric cancer diagnostic procedure market.

Which Segment Divisions Form The Structure Of The Gastric Cancer Diagnostic Procedure Market?

The gastric cancer diagnostic procedure market covered in this report is segmented –

1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types

2) By Symptom Type: Symptomatic, Asymptomatic

3) By Offering Type: Instruments, Reagents And Consumables, Services

4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid

5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer

Subsegments:

1) By Endoscopic Procedure: Upper Endoscopy (EGD), Endoscopic Ultrasound (EUS)

2) By Biopsy: Endoscopic Biopsy, Fine Needle Aspiration (FNA) Biopsy

3) By Tissue Tests: Histopathology, Immunohistochemistry

4) By Lab Tests: Blood Tests, Tumor Markers

5) By In-Vitro Diagnostic Tests: Genetic Testing, Molecular Profiling

6) By Imaging Tests: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scan

7) By Molecular Diagnostics: PCR Testing, Next-Generation Sequencing (NGS)

8) By Multiplexing Molecular Diagnostics: Multiplex PCR, Microarray Analysis

9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)

10) By Other Procedure Types: Breath Tests, Liquid Biopsies

What Trends Are Influencing The Gastric Cancer Diagnostic Procedure Market Outlook?

Leading firms in the gastric cancer diagnostic procedure market are prioritizing technological advancements, such as dual cell-free and exosomal miRNA liquid biopsy assays, to secure a competitive advantage. These diagnostic tools function by measuring small noncoding RNAs found freely in the bloodstream and encapsulated within tumor-derived exosomes, thereby enabling highly sensitive and specific detection of gastric cancer from a simple blood sample. For instance, in December 2024, Cizzle Bio, a U.S.-based biotechnology company, unveiled its DEX G2 blood test. This test merges cell-free and exosomal miRNAs to achieve approximately 95% sensitivity and 97% specificity, requiring only a standard blood draw rather than invasive endoscopy. Although this innovation promises earlier diagnosis and broader screening reach, its widespread acceptance could be limited by regulatory approval timelines and the need for real-world validation.

Which Industry Players Are Present In The Gastric Cancer Diagnostic Procedure Market?

Major companies operating in the gastric cancer diagnostic procedure market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Myriad Genetics Inc., Foundation Medicine Inc., Biocept Inc., Illumina Inc., Roche Diagnostics, QIAGEN N V, Bio‑Rad Laboratories Inc., Siemens Healthineers, Danaher Corporation, Becton Dickinson, bioMérieux SA, PerkinElmer Inc., NeoGenomics Laboratories, Guardant Health Inc., Natera Inc., Caris Molecular Diagnostics, Adaptive Biotechnologies Corp, 10x Genomics Inc

Access The Complete Gastric Cancer Diagnostic Procedure Market Report:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

What Is The Largest Regional Market In The Gastric Cancer Diagnostic Procedure Market?

North America was the largest region in the gastric cancer diagnostics procedure market in 2025. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gastric Cancer Diagnostic Procedure Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Procedure Market 2026, By The Business Research Company

Gastric Cancer Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Ulcers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795